These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11840261)

  • 1. 2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes.
    Van Den Neste E; Cardoen S; Husson B; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Leukemia; 2002 Jan; 16(1):36-43. PubMed ID: 11840261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
    Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxicity of 2-chlorodeoxyadenosine and chlorambucil in chronic lymphocytic leukemia.
    Begleiter A; Wang H; Verburg L; Lee K; Israels LG; Mowat MR; Johnston JB
    Leukemia; 1996 Dec; 10(12):1959-65. PubMed ID: 8946937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil synergizes with purine analogs in inducing in vitro cytotoxicity in B-cell chronic lymphocytic leukemia.
    Callea I; Console G; Sculli G; Filangeri M; Messina G; Morabito F
    Haematologica; 1998 Aug; 83(8):756-7. PubMed ID: 9793266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
    Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
    Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-2'-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB.
    Smal C; Lisart S; Maerevoet M; Ferrant A; Bontemps F; Van Den Neste E
    Biochem Pharmacol; 2007 Feb; 73(3):351-8. PubMed ID: 17137556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia.
    Beck FW; Eilender DS; Dandashi MH; Siddiq F; Snell DC; Godmere MA; Al-Katib AM; Mohammad RM
    Int J Mol Med; 2004 Jul; 14(1):113-9. PubMed ID: 15202025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine.
    Van Den Neste E; Bontemps F; Delacauw A; Cardoen S; Louviaux I; Scheiff JM; Gillis E; Leveugle P; Deneys V; Ferrant A; Van den Berghe G
    Leukemia; 1999 Jun; 13(6):918-25. PubMed ID: 10360381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
    Van den Neste E; Cardoen S; Offner F; Bontemps F
    Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia.
    Lindemalm S; Liliemark J; Gruber A; Eriksson S; Karlsson MO; Wang Y; Albertioni F
    Haematologica; 2003 Mar; 88(3):324-32. PubMed ID: 12651272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill.
    Pepper CJ; Hambly RM; Fegan CD; Delavault P; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6750-5. PubMed ID: 15374993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the ERK pathway promotes apoptosis induced by 2-chloro-2'-deoxyadenosine in the B-cell leukemia cell line EHEB.
    Smal C; Lisart S; Ferrant A; Bontemps F; van den Neste E
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1009-12. PubMed ID: 17065055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia.
    Campàs C; Dalmau M; Montaner B; Barragán M; Bellosillo B; Colomer D; Pons G; Pérez-Tomás R; Gil J
    Leukemia; 2003 Apr; 17(4):746-50. PubMed ID: 12682632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic death of lymphocytes upon treatment with 2-chloro-2'-deoxyadenosine (2-CdA).
    Lassota P; Kazimierczuk Z; Darzynkiewicz Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):17-23. PubMed ID: 7503628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
    Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
    Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions.
    Gandhi V; Estey E; Keating MJ; Chucrallah A; Plunkett W
    Blood; 1996 Jan; 87(1):256-64. PubMed ID: 8547650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes.
    Campàs C; Lopez JM; Santidrián AF; Barragán M; Bellosillo B; Colomer D; Gil J
    Blood; 2003 May; 101(9):3674-80. PubMed ID: 12522004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells.
    Ringshausen I; Oelsner M; Bogner C; Peschel C; Decker T
    Leukemia; 2008 Mar; 22(3):635-8. PubMed ID: 17805332
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.